Aviad Friedman - Director, Oramed Pharmaceuticals Inc
As of January 5, 2022
What is Aviad Friedman's Net Worth?
The current estimated net worth of Oramed Pharmaceuticals Inc's Director, Aviad Friedman, is estimated to be about $59.92K . Aviad Friedman owns about 22,191 units of Oramed Pharmaceuticals Inc common stock. In the last 5 years at Oramed Pharmaceuticals Inc, Aviad Friedman has sold an estimated value of $0 worth.
What is Aviad Friedman's Past Insider Trading?
Aviad Friedman's largest purchase order was 2,500 units , worth over $12.37K on August 13, 2018. In total, Aviad Friedman has made about 5 transactions over 5 years of their time at Oramed Pharmaceuticals Inc. Aviad Friedman usually trades in January, with the busiest year in 2017.
Aviad Friedman
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Aviad Friedman's' Mailing Address?
- Mailing address is Hadassa 6 Tel Aviv L3 6451306 Israel
Oramed Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Nadav Kidron | 2020 | $439,076 | $220,582 | $569,062 | $539,131 | $1,767,851 |
| Nadav Kidron | 2019 | $419,460 | $224,975 | $398,910 | $507,750 | $1,551,095 |
| Nadav Kidron | 2018 | $436,310 | $148,795 | $522,569 | $442,326 | $1,550,000 |
| Miriam Kidron | 2020 | $305,840 | $70,000 | $299,506 | $13,354 | $688,700 |
| Miriam Kidron | 2019 | $267,386 | $123,149 | $211,128 | $14,503 | $616,166 |
| Miriam Kidron | 2018 | $273,595 | $46,614 | $253,204 | $13,643 | $587,056 |
| Avraham Gabay | 2020 | $130,554 | $15,591 | - | $44,912 | $191,418 |
| Avraham Gabay | 2019 | $32,122 | - | $73,928 | $9,441 | $115,491 |
| Joshua Hexter | 2020 | $190,801 | $12,169 | $351,128 | $54,735 | $608,833 |
| Joshua Hexter | 2019 | $52,848 | - | - | $9,022 | $61,870 |
| Joshua Hexter | 2018 | $161,002 | $26,895 | $269,196 | $50,505 | $507,598 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm
What are Oramed Pharmaceuticals Inc's Past Insider Trades?
Oramed Pharmaceuticals Inc's most recent insider trade came on May 10, 2022 by Arie Mayer who sold 3,000 units worth $76.8K . In the last 13 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.22M and bought an estimated value of $6.11M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Miriam Kidron, Chief Scientific Officer, Nadav Kidron, President and CEO, and Leonard Sank, Director .
ORAMED PHARMACEUTICALS INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||